Bioventus · 3 hours ago
Sr Territory Manager - Pain/Peripheral Nerve Stimulation (Orange County CA)
Bioventus is dedicated to developing its people and fostering a diverse team to help patients lead active lives. They are seeking a Senior Territory Manager for Peripheral Nerve Stimulation who will be responsible for achieving sales quotas, developing business plans, and collaborating with sales and marketing teams to drive success in their territory.
Health CareHealth DiagnosticsMedical Device
Responsibilities
Achieve sales quotas for assigned channels and product groups, and establish and execute quarterly and annual key performance metrics
Conduct in-services and meetings by delivering company-developed presentations to groups of physicians, hospital administration, and clinicians
Develop and execute annual business plans within the assigned geography
Review quarterly key performance metrics with management to set execution goals for the territory
Assist management with planning for and co-presenting in team meetings, conference calls, and national and regional trade shows
Monitor national sales vs quota and assist management in identifying areas of opportunity needing focus
Hold self and others accountable for conducting business in a manner compliant with Bioventus’ Code of Compliance and Ethics, policies and procedures, and internal controls applicable to their role
Qualification
Required
4-year degree
at least 5 years of proven sales experience (delivering against a quota)
strong business-to-business selling experience
results-focused
self-motivated
strong interpersonal skills to build effective, lasting relationships among key decision-makers
ability to effectively communicate
problem-solve
adapt to a fast-changing environment with ease
dedication to teamwork
commitment to excellence
Preferred
preferably in the neuromodulation, biotech, life science, medical device, or related industry
Company
Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely.
Funding
Current Stage
Public CompanyTotal Funding
$827MKey Investors
Wells Fargo
2025-07-31Post Ipo Debt· $400M
2022-04-26Post Ipo Debt· $415M
2021-02-10IPO
Leadership Team
Recent News
2025-12-09
Company data provided by crunchbase